Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma
Clinical trial NCT03328104 · COMPLETED
Trial details
- NCT number
- NCT03328104
- Sponsor
- Emory University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-24
- Primary completion
- 2023-06-29
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.